Statistics
Publications
3
Citations
48
H-Index
3
Active since
2020
Pamela Dow is an author at Research & Development Institute specializing in pharmacology, drug-drug interaction risk, and risk-benefit ratio assessment.
Publications per year
2020–2021
3
3
Sweilem B. Al Rihani, Matt K. Smith, Ravil Bikmetov et al. · Journal of Clinical Medicine · 2020 · 23 citations · Full text
Tao Long, Rodrigo Cristofoletti, Brian Cicali et al. · The Journal of Clinical Pharmacology · 2021 · 13 citations · Full text
Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugs
Véronique Michaud, Pamela Dow, Sweilem B. Al Rihani et al. · medRxiv · 2020 · 12 citations · Full text
1–3 of 3